(E)-Fluvoxamine-d3 maleate

• CAT Number: S000392
• CAS Number: 1185245-56-0
• Molecular Formula: C19H22D3F3N2O6
• Molecular Weight: 437.40
• Purity: ≥95%
• IUPAC Name: (Z)-but-2-enedioic acid;2-[(Z)-[5-(trideuteriomethoxy)-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
• InChI: InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14-;2-1-/i1D3
• InChIKey: LFMYNZPAVPMEGP-ATJUTURBSA-N
• SMILES: COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O

(E)-Fluvoxamine-d3 maleate（Cat No.:S000392） is a deuterated version of fluvoxamine maleate, where three hydrogen atoms are replaced with deuterium. This structural modification enhances the drug’s metabolic stability, aiding in detailed pharmacokinetic research. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for treating obsessive-compulsive disorder (OCD) and depression. It functions by increasing serotonin levels in the brain, which helps improve mood and reduce anxiety. The maleate salt form improves the solubility of fluvoxamine. The deuterated version, (E)-Fluvoxamine-d3 maleate, provides valuable insights into the drug’s absorption, distribution, metabolism, and elimination processes.